<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37647325</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>8</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>A computational approach to fighting type 1 diabetes by targeting 2C Coxsackie B virus protein with flavonoids.</ArticleTitle><Pagination><StartPage>e0290576</StartPage><MedlinePgn>e0290576</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0290576</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0290576</ELocationID><Abstract><AbstractText>Autoimmune diabetes, well-known as type 1 insulin-dependent diabetic mellitus (T1D). T1D is a prolonged condition marked by an inadequate supply of insulin. The lack is brought on by pancreatic cell death and results in hyperglycemia. The immune system, genetic predisposition, and environmental variables are just a few of the many elements that contribute significantly to the pathogenicity of T1D disease. In this study, we test flavonoids against Coxsackie virus protein to cope the type 1 diabetes. After protein target identification we perform molecular docking of flavonoids and selected target (1z8r). then performed the ADMET analysis and select the top compound the base of the docking score and the ADMET test analysis. Following that molecular dynamics simulation was performed up to 300 ns. Root means square deviation, root mean square fluctuation, secondary structure elements, and protein-ligand contacts were calculated as post-analysis of simulation. We further check the binding of the ligand with protein by performing MM-GBSA every 10 ns. Lead compound CID_5280445 was chosen as a possible medication based on analysis. The substance is non-toxic, meets the ADMET and BBB likeness requirements, and has the best interaction energy. This work will assist researchers in developing medicine and testing it as a treatment for Diabetes Mellitus Type 1 brought on by Coxsackie B4 viruses by giving them an understanding of chemicals against these viruses.</AbstractText><CopyrightInformation>Copyright: © 2023 Ullah et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ullah</LastName><ForeName>Shahid</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6694-5590</Identifier><AffiliationInfo><Affiliation>S Khan Lab Mardan, Khyber Pakhtunkhwa, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zilong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Big Data Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Wajeeha</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>S Khan Lab Mardan, Khyber Pakhtunkhwa, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ullah</LastName><ForeName>Farhan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>S Khan Lab Mardan, Khyber Pakhtunkhwa, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ullah</LastName><ForeName>Anees</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>S Khan Lab Mardan, Khyber Pakhtunkhwa, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Muhammad Nasir</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Institute of Biochemistry, Biotechnology and Bioinformatics, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Naveed</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Institute of Biochemistry, Biotechnology and Bioinformatics, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Tianshun</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Big Data Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, P. R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005419">Flavonoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005419" MajorTopicYN="N">Flavonoids</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056004" MajorTopicYN="N">Molecular Dynamics Simulation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>13</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37647325</ArticleId><ArticleId IdType="pmc">PMC10468086</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0290576</ArticleId><ArticleId IdType="pii">PONE-D-23-08995</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roep BO. The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure. Diabetologia. 2003;46(3):305–21. doi: 10.1007/s00125-003-1089-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-003-1089-5</ArticleId><ArticleId IdType="pubmed">12687328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrmann D, Kulzer B, Roos T, Haak T, Al-Khatib M, Hermanns N. Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes. Lancet Diabetes Endocrinol. 2020;8(5):436–46. doi: 10.1016/S2213-8587(20)30042-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30042-5</ArticleId><ArticleId IdType="pubmed">32333879</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020;10(2):98–115. doi: 10.34172/hpp.2020.18</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/hpp.2020.18</ArticleId><ArticleId IdType="pmc">PMC7146037</ArticleId><ArticleId IdType="pubmed">32296622</ArticleId></ArticleIdList></Reference><Reference><Citation>Leslie RD, Evans-Molina C, Freund-Brown J, Buzzetti R, Dabelea D, Gillespie KM, et al.. Adult-Onset Type 1 Diabetes: Current Understanding and Challenges. Diabetes Care. 2021;44(11):2449–56. doi: 10.2337/dc21-0770</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-0770</ArticleId><ArticleId IdType="pmc">PMC8546280</ArticleId><ArticleId IdType="pubmed">34670785</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, et al.. Correction to: The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022;65(1):255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8895052</ArticleId><ArticleId IdType="pubmed">34851428</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ. 2011;342:d35. doi: 10.1136/bmj.d35</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d35</ArticleId><ArticleId IdType="pmc">PMC3033438</ArticleId><ArticleId IdType="pubmed">21292721</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaidane H, Sauter P, Sane F, Goffard A, Gharbi J, Hober D. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship. Rev Med Virol. 2010;20(5):265–80. doi: 10.1002/rmv.647</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.647</ArticleId><ArticleId IdType="pubmed">20629044</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, Tanaka S, Aida K. Unique pathological changes in the pancreas of fulminant type 1 diabetes. Diabetol Int. 2020;11(4):323–8. doi: 10.1007/s13340-020-00462-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13340-020-00462-6</ArticleId><ArticleId IdType="pmc">PMC7538509</ArticleId><ArticleId IdType="pubmed">33088638</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, Aida K, Nishida Y, Kobayashi T. Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes. Endocr J. 2013;60(7):837–45. doi: 10.1507/endocrj.ej13-0222</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.ej13-0222</ArticleId><ArticleId IdType="pubmed">23774118</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua MP, Mercier A, Vergez I, Morvan C, Mbani CJ, Sane F, et al.. [Coxsackievirus B infection and pathogenesis of type 1 diabetes]. Virologie (Montrouge). 2022;26(6):415–30.</Citation><ArticleIdList><ArticleId IdType="pubmed">36565260</ArticleId></ArticleIdList></Reference><Reference><Citation>Emekdas G, Rota S, Kustimur S, Kocabeyoglu O. [Antibody levels against coxsackie B viruses in patients with type 1 diabetes mellitus]. Mikrobiyol Bul. 1992;26(2):116–20.</Citation><ArticleIdList><ArticleId IdType="pubmed">1316989</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua MP, Alidjinou EK, Hober D. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol. 2022;18(8):503–16. doi: 10.1038/s41574-022-00688-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00688-1</ArticleId><ArticleId IdType="pmc">PMC9157043</ArticleId><ArticleId IdType="pubmed">35650334</ArticleId></ArticleIdList></Reference><Reference><Citation>Banatvala JE. Insulin-dependent (juvenile-onset, type 1) diabetes mellitus Coxsackie B viruses revisited. Prog Med Virol. 1987;34:33–54.</Citation><ArticleIdList><ArticleId IdType="pubmed">2821577</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin H, Berg AK, Tuvemo T, Frisk G. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes. 2002;51(6):1964–71. doi: 10.2337/diabetes.51.6.1964</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.51.6.1964</ArticleId><ArticleId IdType="pubmed">12031987</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyoty H, Hiltunen M, Lonnrot M. Enterovirus infections and insulin dependent diabetes mellitus—evidence for causality. Clin Diagn Virol. 1998;9(2–3):77–84. doi: 10.1016/s0928-0197(98)00007-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0928-0197(98)00007-5</ArticleId><ArticleId IdType="pubmed">9645988</ArticleId></ArticleIdList></Reference><Reference><Citation>Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia. 2002;45(5):693–702. doi: 10.1007/s00125-002-0805-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-002-0805-x</ArticleId><ArticleId IdType="pubmed">12107750</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasov AG, Zotchev SB, Dirsch VM, Orhan IE, Banach M, Rollinger JM, et al.. Natural products in drug discovery: advances and opportunities. Nature Reviews Drug Discovery. 2021;20(3):200–16. doi: 10.1038/s41573-020-00114-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-020-00114-z</ArticleId><ArticleId IdType="pmc">PMC7841765</ArticleId><ArticleId IdType="pubmed">33510482</ArticleId></ArticleIdList></Reference><Reference><Citation>Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. Journal of Nutritional Science. 2016;5:e47. doi: 10.1017/jns.2016.41</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/jns.2016.41</ArticleId><ArticleId IdType="pmc">PMC5465813</ArticleId><ArticleId IdType="pubmed">28620474</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter NJ, Roetzer A, Liebig HD, Sedelnikova SE, Hounslow AM, Skern T, et al.. Structure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart disease. J Virol. 2006;80(3):1451–62. doi: 10.1128/JVI.80.3.1451-1462.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.3.1451-1462.2006</ArticleId><ArticleId IdType="pmc">PMC1346940</ArticleId><ArticleId IdType="pubmed">16415022</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al.. The Protein Data Bank. Nucleic Acids Res. 2000;28(1):235–42. doi: 10.1093/nar/28.1.235</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/28.1.235</ArticleId><ArticleId IdType="pmc">PMC102472</ArticleId><ArticleId IdType="pubmed">10592235</ArticleId></ArticleIdList></Reference><Reference><Citation>Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, et al.. Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics. 2006;Chapter 5:Unit-5 6. doi: 10.1002/0471250953.bi0506s15</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471250953.bi0506s15</ArticleId><ArticleId IdType="pmc">PMC4186674</ArticleId><ArticleId IdType="pubmed">18428767</ArticleId></ArticleIdList></Reference><Reference><Citation>Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997;18(15):2714–23. doi: 10.1002/elps.1150181505</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/elps.1150181505</ArticleId><ArticleId IdType="pubmed">9504803</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho BK, Brasseur R. The Ramachandran plots of glycine and pre-proline. BMC Struct Biol. 2005;5:14. doi: 10.1186/1472-6807-5-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6807-5-14</ArticleId><ArticleId IdType="pmc">PMC1201153</ArticleId><ArticleId IdType="pubmed">16105172</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian W, Chen C, Lei X, Zhao J, Liang J. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 2018;46(W1):W363–W7. doi: 10.1093/nar/gky473</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky473</ArticleId><ArticleId IdType="pmc">PMC6031066</ArticleId><ArticleId IdType="pubmed">29860391</ArticleId></ArticleIdList></Reference><Reference><Citation>Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–61. doi: 10.1002/jcc.21334</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21334</ArticleId><ArticleId IdType="pmc">PMC3041641</ArticleId><ArticleId IdType="pubmed">19499576</ArticleId></ArticleIdList></Reference><Reference><Citation>Mura C, McCrimmon CM, Vertrees J, Sawaya MR. An introduction to biomolecular graphics. PLoS Comput Biol. 2010;6(8). doi: 10.1371/journal.pcbi.1000918</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1000918</ArticleId><ArticleId IdType="pmc">PMC2928806</ArticleId><ArticleId IdType="pubmed">20865174</ArticleId></ArticleIdList></Reference><Reference><Citation>Systèmes D. BIOVIA Discovery Studio. San Diego. 2022.</Citation></Reference><Reference><Citation>Pires DE, Blundell TL, Ascher DB. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J Med Chem. 2015;58(9):4066–72. doi: 10.1021/acs.jmedchem.5b00104</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.5b00104</ArticleId><ArticleId IdType="pmc">PMC4434528</ArticleId><ArticleId IdType="pubmed">25860834</ArticleId></ArticleIdList></Reference><Reference><Citation>Laoui A, Polyakov VR. Web services as applications’ integration tool: QikProp case study. J Comput Chem. 2011;32(9):1944–51. doi: 10.1002/jcc.21778</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21778</ArticleId><ArticleId IdType="pubmed">21455963</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowers KJaC David E. and Xu Huafeng and Dror, Ron O. and Eastwood, Michael P. and Gregersen, Brent A. and Klepeis, et al.. Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters: IEEE; 2006. 43– p.</Citation></Reference><Reference><Citation>Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules. 2015;20(7):13384–421. doi: 10.3390/molecules200713384</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules200713384</ArticleId><ArticleId IdType="pmc">PMC6332083</ArticleId><ArticleId IdType="pubmed">26205061</ArticleId></ArticleIdList></Reference><Reference><Citation>Hildebrand PW, Rose AS, Tiemann JKS. Bringing Molecular Dynamics Simulation Data into View. Trends Biochem Sci. 2019;44(11):902–13. doi: 10.1016/j.tibs.2019.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2019.06.004</ArticleId><ArticleId IdType="pubmed">31301982</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasheed MA, Iqbal MN, Saddick S, Ali I, Khan FS, Kanwal S, et al.. Identification of Lead Compounds against Scm (fms10) in Enterococcus faecium Using Computer Aided Drug Designing. Life (Basel). 2021;11(2). doi: 10.3390/life11020077</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life11020077</ArticleId><ArticleId IdType="pmc">PMC7909823</ArticleId><ArticleId IdType="pubmed">33494233</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivakumar D, Williams J, Wu Y, Damm W, Shelley J, Sherman W. Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field. Journal of Chemical Theory and Computation. 2010;6(5):1509–19. doi: 10.1021/ct900587b</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ct900587b</ArticleId><ArticleId IdType="pubmed">26615687</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant BJ, Skjaerven L, Yao XQ. The Bio3D packages for structural bioinformatics. Protein Sci. 2021;30(1):20–30. doi: 10.1002/pro.3923</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3923</ArticleId><ArticleId IdType="pmc">PMC7737766</ArticleId><ArticleId IdType="pubmed">32734663</ArticleId></ArticleIdList></Reference><Reference><Citation>Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA, Khan IA, et al.. Luteolin, a flavonoid, as an anticancer agent: A review. Biomed Pharmacother. 2019;112:108612. doi: 10.1016/j.biopha.2019.108612</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.108612</ArticleId><ArticleId IdType="pubmed">30798142</ArticleId></ArticleIdList></Reference><Reference><Citation>David CC, Jacobs DJ. Principal component analysis: a method for determining the essential dynamics of proteins. Methods Mol Biol. 2014;1084:193–226. doi: 10.1007/978-1-62703-658-0_11</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-658-0_11</ArticleId><ArticleId IdType="pmc">PMC4676806</ArticleId><ArticleId IdType="pubmed">24061923</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>